Literature DB >> 11855825

Regulation of cap-dependent translation by insulin-like growth factor-1 in neuronal cells.

Celia Quevedo1, Matilde Salinas, Alberto Alcázar.   

Abstract

Insulin-like growth factor-1 (IGF-1) both promotes survival and activates protein synthesis in neurons. In the present paper, we investigate the effect of IGF-1 treatment on cap-dependent translation in primary cultured neuronal cells. IGF-1 treatment increased the phosphorylation of eukaryotic initiation factor (eIF)-4E-binding protein 1 (4E-BP1), exclusively at Thr-36 and Thr-45 residues, and eIF-4G phosphorylation at Ser-1108. In contrast, a significant eIF-4E dephosphorylation was found. In parallel, increased eIF-4E/4G assembly and protein synthesis activation in response to IGF-1 treatment were observed. The phosphatidylinositol 3-kinase (PI3-K) inhibitor wortmannin and the mammalian target of rapamycin (mTOR) inhibitor rapamycin, but not the mitogen-activated protein kinase (MAPK)-activating kinase (MEK) inhibitor PD98059, reversed the IGF-1-induced effects observed on eIF-4E/4G assembly and phosphorylation status of 4E-BP1, eIF-4E, and eIF-4G. Therefore, our findings show that the IGF-1-induced regulation of cap-dependent translation is largely dependent on the PI-3K and mTOR pathway in neuronal cells. ©2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11855825     DOI: 10.1006/bbrc.2002.6479

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

Review 1.  The insulin-like growth factor system and the fetal brain: effects of poor maternal nutrition.

Authors:  Thomas J McDonald; Mark J Nijland; Peter W Nathanielsz
Journal:  Rev Endocr Metab Disord       Date:  2007-06       Impact factor: 6.514

Review 2.  The neurology of mTOR.

Authors:  Jonathan O Lipton; Mustafa Sahin
Journal:  Neuron       Date:  2014-10-22       Impact factor: 17.173

3.  New hierarchical phosphorylation pathway of the translational repressor eIF4E-binding protein 1 (4E-BP1) in ischemia-reperfusion stress.

Authors:  María I Ayuso; Macarena Hernández-Jiménez; María E Martín; Matilde Salinas; Alberto Alcázar
Journal:  J Biol Chem       Date:  2010-08-24       Impact factor: 5.157

Review 4.  Cerebellar Development and Autism Spectrum Disorder in Tuberous Sclerosis Complex.

Authors:  Maria Sundberg; Mustafa Sahin
Journal:  J Child Neurol       Date:  2015-08-24       Impact factor: 1.987

5.  Dissociation of eIF4E-binding protein 2 (4E-BP2) from eIF4E independent of Thr37/Thr46 phosphorylation in the ischemic stress response.

Authors:  María I Ayuso; Emma Martinez-Alonso; Nelida Salvador; Petra Bonova; Ignacio Regidor; Alberto Alcázar
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

Review 6.  mTOR signaling and its roles in normal and abnormal brain development.

Authors:  Nobuyuki Takei; Hiroyuki Nawa
Journal:  Front Mol Neurosci       Date:  2014-04-23       Impact factor: 5.639

Review 7.  mTOR-Dependent Cell Proliferation in the Brain.

Authors:  Larisa Ryskalin; Gloria Lazzeri; Marina Flaibani; Francesca Biagioni; Stefano Gambardella; Alessandro Frati; Francesco Fornai
Journal:  Biomed Res Int       Date:  2017-11-13       Impact factor: 3.411

8.  Downregulation of Mcl-1 through inhibition of translation contributes to benzyl isothiocyanate-induced cell cycle arrest and apoptosis in human leukemia cells.

Authors:  T Zhou; G Li; B Cao; L Liu; Q Cheng; H Kong; C Shan; X Huang; J Chen; N Gao
Journal:  Cell Death Dis       Date:  2013-02-28       Impact factor: 8.469

Review 9.  A possible link between BDNF and mTOR in control of food intake.

Authors:  Nobuyuki Takei; Kazuo Furukawa; Osamu Hanyu; Hirohito Sone; Hiroyuki Nawa
Journal:  Front Psychol       Date:  2014-09-25

10.  Phloroglucinol induces apoptosis through the regulation of insulin-like growth factor 1 receptor signaling pathways in human colon cancer HT-29 cells.

Authors:  Mi-Hye Kang; In-Hye Kim; Taek-Jeong Nam
Journal:  Int J Oncol       Date:  2014-06-24       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.